Galena plummets after halting NeuVax study

Galena Biopharma Inc. (NASDAQ:GALE) lost $1.68 (83%) to $0.35 on Wednesday after it said it

Read the full 154 word article

How to gain access

Continue reading with a
two-week free trial.